Sandra Rosenberg, ARNP

Sandra Rosenberg practices at UMiami Medicine - Urology in Miami, Florida.

Sandra Rosenberg's NPI, 1710490792, was assigned on November 13, 2017. Sandra Rosenberg holds Florida license 9327557.

Sandra Rosenberg's primary practice is UMiami Medicine - Urology, at 1150 Nw 14th St, Miami, FL 33136 in Miami-Dade County. The practice phone is (305) 243-7688.

Sandra Rosenberg's primary practice is UMiami Medicine - Urology in Miami, Florida. Sandra Rosenberg is also affiliated with Sylvester Comprehensive Cancer Center. The medical group on file is University of Miami Health System. Dmand AI also links Sandra Rosenberg to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Sandra Rosenberg practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatric/mental health is Sandra Rosenberg's primary specialty in the NPI Registry, under taxonomy code 363LP0808X. Sandra Rosenberg is licensed in Florida.

Dmand AI lists enlarged prostate, intellectual and developmental disabilities and UTI among the conditions Sandra Rosenberg treats.

CMS data shows 307 Medicare services from Sandra Rosenberg across 5 procedure codes in 2024, for 158 Medicare patients. Medicare paid $13,619 for them. Every service was in an office.

CMS counts 158 Medicare patients who saw Sandra Rosenberg in 2024. The largest group is 65 to 74, with 57 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 51% are also on Medicaid. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Sandra Rosenberg's median patient age at 66, with 30% women.

In 2024, Sandra Rosenberg wrote 1,361 Medicare Part D claims for 432 patients. 81% of them were for generic drugs. CMS names the drug for 1,220 of them, across 20 drugs with 11 or more claims each, at $235,564 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Sandra Rosenberg for performance year 2024, reported as part of a group. Sandra Rosenberg accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Sandra Rosenberg as offering telehealth.

CMS Open Payments shows 44 general payments to Sandra Rosenberg from 17 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 91% of the total. Janssen Pharmaceuticals, Inc paid the most, $214.